Innovation and industrial leadership : lessons from pharmaceuticals / by Fabio Pammolli and Massimo Riccaboni.

Includes biliographical references.

Chapter I. Executive Summary -- Chapter II. Productivity and Competitiveness -- Main Findings -- II.1. Overview -- II.2. International Comparison of Labor Productivity -- II.3. Pharmaceutical Cost Competitiveness -- II.4. Growth Decomposition and Total Factor Productivity -- II.5. The Role of Institutions -- Chapter III. Main Structural Indicators -- Main Findings -- III.1. Overview -- III.2. Trade, Growth and the Size of the Market -- III.3. Size, Barriers and "the Mystery of Missing Trade" -- III.4. Trade, Outsourcing and Offshoring -- III.5. Size, Internationalization and Competitiveness -- Appendix III.2. Tax Incentives and Foreign Direct Investment: The Irish Case -- Chapter IV. R&D and Innovation -- Main Findings -- IV.1. Overview -- IV.2. Some Plausible Explanations of the R&D Productivity Slowdown -- IV.3. Global Competition in Pharmaceutical R&D -- IV.4. The International System of Division of Innovative Labor -- IV.5. National Systems of Innovation in Biopharmaceuticals -- Part V. Industry Structure and Competition -- Main Findings -- V.1. Overview -- V.2. The Determinants of Market Growth -- V.3. Market Competition -- Appendix V.2. Market Regulation, Innovation and Competition -- Part VI. Conclusions -- Figure II.1. Labor productivity, EU vs. U.S., manufacturing and pharmaceuticals, 1980-2001 (U.S.=100) -- Figure II.2. Relative labor productivity versus share of pharmaceuticals over manufacturing, 2001 -- Figure II.3. Annual Real Effective Exchange Rates (REER) of the U.S. and EU-15 against the rest of the IC24 group -- Figure II.4. Labor cost per employee for the EU in manufacturing and pharmaceuticals vis-a-vis the U.S., 1980-2001 -- Figure II.5. Temporal evolution of RULC and its components for the EU-8 aggregate -- Figure II.6. Decomposition of value added trend growth for the U.S., France, Germany and UK -- Figure III.1. Pharmaceutical market size versus total production, 2003 -- Figure III.2. Departures from the gravity model of trade flows (import/export) in pharmaceuticals as compared to total manufacturing -- Figure III.3. The U.S. trade balance in pharmaceuticals -- Figure III.4. Share of turnover of affiliates under foreign control in chemicals and pharmaceuticals, 2001.